BioOutsource Bioanalysis Experts Attending Major Biosimilar Conferences November 16-19
Offering scientists an opportunity for face-to-face meetings to discuss strategies for accelerating biosimilar development
12 Nov 2015
Sartorius Stedim Biotech (SSB) BioOutsource has announced its expert technical staff will be speaking at and/or attending BIOLATAM, Biosimilars LATAM and Biosimilars and Biobetters conferences from November 16-19. This will provide developers of biosimilars with an excellent opportunity to discuss the optimum assay design for rapid and accurate biosimilar characterization and comparison studies.
At BIOLATAM 2015 in Chile, scientists will be able to hear bioanalysis expert, Dr Verna McErlane, Director of Business Development for Americas, at SSB BioOutsource presenting on Tuesday, November 17 from 3–4pm in the Salón El Canelo. In a session entitled, ‘Integrated solutions and services from research to production in bioprocess’ Dr McErlane will explain the types of bioanalytical testing available and how to select the right assays for characterizing biological activity from discovery through the clinical phases of biologics development.
McErlane is presenting alongside, bioprocess specialist, Javier Lobo, Field Marketing Manager Latin America, Application Specialist Spain-Portugal, Fermentation Technologies at SSB Spain. Lobo will detail how bioanalytical testing is integrated with innovative upstream and downstream bioprocess development, making this a must-visit presentation at BIOLATAM for any scientists looking to ensure they have the latest information about the most rapid and cost-effective, strategies for developing their biosimilars.
Researchers that cannot attend the presentation can also connect with Dr McErlane and Javier Lobo, as well as other bioprocess experts on SSB booth #20.
Following BIOLATAM, Dr McErlane, will be attending Biosimilars LATAM 2015 in Brazil where she would welcome technical meetings and discussions with scientists requiring advice on the types of bioanalysis to utilize when developing biosimilars.
Also available for discussion about the range of assays for biosimilar characterization and comparability is bioanalysis expert, Dr Catriona Thomson Associate Director of Bioanalytical Technical Services, at SSB BioOutsource. Dr Thomson is attending Biosimilars and Biobetters 2015 in the USA
Dr Verna McErlane at SSB BioOutsource commented: “Selecting the best analytical tools to use for biosimilar characterization and comparability can be very daunting. This is being made more complicated as regulators are becoming increasingly demanding in respect to sensitivity and accuracy of assays to prove comparability between innovator and biosimilar drugs.
McErlane continued: “I’m delighted that Catriona Thomson and I are going to be at these major biosimilar conferences in November as this allows us to meet scientists and explore the issues they have with their testing. We look forward to meeting them and to discussing which bioanalytical strategies they should consider adopting for optimizing the timelines and costs of their biosimilar development.”
Related Products
Request Quote for All Products
BIOSTAT® B – The Gold Standard of Benchtop Bioreactors
Sartorius GroupThe BIOSTAT® B fermenter | bioreactor has been specially designed to cover the wide variety of requirements in biotechnological and biopharmaceutical research and development. With several thousands of units installed worldwide, BIOSTAT® B is the most successful autoclavable system of its class and is now available in the third generation. A wide range of configurations is available to choose from for animal, plant and insect cell cultivation as well as for microbial fermentation. The process controller can be combined either with reusable stirred glass vessels or with single-use bioreactors made of pre-sterilized polycarbonate. Volumes range from 1L to 2L and from 5L to 10L. The system is capable of controlling either one or two vessels completely independently from each other. Designed to meet your specific needs, BIOSTAT® B covers a wide range of applications, extending from use as a flexible basic unit for preclinical research to a fully qualified system that complies with the requirements of a validated GMP environment. Typical areas of application include the following: Process development for the manufacture of vaccines, recombinant proteins and monoclonal antibodies Process strategy development using a batch, fed-batch, continuous or perfusion mode Scale-up and scale-down tests for commercial-scale manufacture Small-scale (pre-)production High cell-density fermentation Adherent cell cultures on microcarriers Low-shear-stress cell cultivation of sensitive organisms Cultivation of filamentous organisms Biofuel manufacturing Dual usage both for cell cultures and microbial applications, such as in academic research
Biosart® 100 Monitors
Sartorius GroupThe Biosart® 100 Monitors have been specifically designed for the detection and enumeration of microorganisms in pharmaceuticals, cosmetics, food, beverages, water and other liquids. The monitors are sterile funnels, ready-to-use due to the incorporated membrane filter and cellulose pad. After filtration, just remove the 100 ml funnel to convert the monitor into a petri dish, eliminating the need of membrane manipulation.